Journals / Turkish Thoracic Journal / 2019 / Cilt: 20 - Sayı: 3

What Factors Influence Non-Adherence to the Smoking Cessation Program?

Pages
168–174
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Multivariable logistic regression analysis showed that the age to begin smoking (p=0.045, odds ratio (OR):1.05, 95% confidence interval (CI): 0.86-0.99) and pharmacotherapy (p<0.0001, OR: 5.00, 95% CI: 2.80-8.94) were independent variables that affected adherence to the program.CONCLUSION: Care should be taken in the follow-up period when providing no pharmacotherapy and with subjects who started smoking at a young age.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: To improve our knowledge and understand how to deal with non-adherence to the support programs and to determine therate and possible factors related to non-adherence in subjects who attended our smoking cessation clinic.MATERIALS AND METHODS: This was a case-control study that included 550 subjects who applied to our smoking cessation clinicbetween June 1, 2011 and December 31, 2011.
📊
Key Findings & Data:After a 1-year follow-up period, subjects were divided into two groups: adherent (controls) and non-adherent (cases).
💡
Conclusion & Impact:Multivariable logistic regression analysis showed that the age to begin smoking (p=0.045, odds ratio (OR):1.05, 95% confidence interval (CI): 0.86-0.99) and pharmacotherapy (p<0.0001, OR: 5.00, 95% CI: 2.80-8.94) were independent variables that affected adherence to the program.CONCLUSION: Care should be taken in the follow-up period when providing no pharmacotherapy and with subjects who started smoking at a young age.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Özet

OBJECTIVES: To improve our knowledge and understand how to deal with non-adherence to the support programs and to determine therate and possible factors related to non-adherence in subjects who attended our smoking cessation clinic.MATERIALS AND METHODS: This was a case-control study that included 550 subjects who applied to our smoking cessation clinicbetween June 1, 2011 and December 31, 2011. After a 1-year follow-up period, subjects were divided into two groups: adherent (controls) and non-adherent (cases). Sociodemographic and clinical parameters and smoking habits were evaluated. A p value <0.05 wasconsidered significant.RESULTS: Of the 550 subjects, the number of cases (non-adherent) was 135 (24.6%), and the number of controls (adherent) was 415(75.4%). Age to begin smoking was significantly young in subjects with non-adherence to the program (p=0.026). The rate of receivingpharmacotherapy was significantly high in subjects with adherence (p<0.0001). No difference was found between the groups accordingto varenicline, bupropion, nicotine gum, or combined therapy use, whereas nicotine patch use alone significantly increased the rate ofnon-adherence (p=0.022). Multivariable logistic regression analysis showed that the age to begin smoking (p=0.045, odds ratio (OR):1.05, 95% confidence interval (CI): 0.86-0.99) and pharmacotherapy (p<0.0001, OR: 5.00, 95% CI: 2.80-8.94) were independent variables that affected adherence to the program.CONCLUSION: Care should be taken in the follow-up period when providing no pharmacotherapy and with subjects who started smoking at a young age.

🔖

Cite This Article

KOÇAK, N. D., AKTÜRK, Ü. A. (2019). What Factors Influence Non-Adherence to the Smoking Cessation Program?. Turkish Thoracic Journal, Cilt: 20 - Sayı: 3, 168–174. https://ajindex.com/articles/418009

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. World Health Organization. WHO Report on the Global Tobacco Epidemic. Enforcing bans on tobacco advertising, promotion and sponsorship. Geneva, Switzerland: World Health Organization; 2013. Available from: URL: http://www.who.int/ tobacco/global_report/2013/en/
  2. Bilir N, Çakır B, Dağlı E, et al. WHO Europe Tobacco control in Turkey. World Health Organization Denmark; 2009. Available from: URL:
  3. Global Adult Tobacco Survey Turkey. Public Health Institution. Ankara, Turkey; 2014. Available from: URL: http://www.who.int/ tobacco/surveillance/survey/gats/report_tur_2012.pdf
  4. Çelik İ, Yüce D, Hayran M, et al. Nationwide smoking cessation treatment support program-Turkey Project. Health Policy 2015;119:50-6
  5. Raupach T, Brown J, Herbec A, et al. A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success. Addiction 2014;109:35-43. [CrossRef] 6. Wen KY, Miller SM, Lazev A, et al. Predictors of smoking cessation counseling adherence in a socioeconomically disadvantaged sample of pregnant women. J Health Care Poor Underserved 2012;23:1222-38. [CrossRef] 7. Balmford J, Borland R, Hammond D, et al. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res 2011;13:94-102. [CrossRef] 8. Bahadir A, Iliaz S, Yurt S, et al. Factors affecting dropout in the smoking cessation outpatient clinic. Chron Respir Dis 2016;13:155-61. [CrossRef] 9. Siddiqui O, Flay BR, Hlu FB. Factors affecting attrition in a longitudinal smoking prevention study. Prev Med 1996;25:554-60. [CrossRef] 10. Hays JT, Leischow SJ, Lawrence D, et al. Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence. Nicotine Tob Res 2010;12:574-81. [CrossRef] 11. World Health Organization: Adherence to Long-term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003. Available from: URL: http://apps.who.int/ iris/bitstream/10665/42682/1/9241545992.pdf
  6. Afzal Z, Pogge E, Boomershine V. Evaluation of pharmacist and nurse practitioner smoking cessation program. J Pharm Pract 2017;30:406-11. [CrossRef] 13. Marino MG, Fusconi E, Magnatta R, et al. Epidemiologic determinants affecting cigarette smoking cessation: a retrospective study in a National Health System (SSN) treatment service in Rome (Italy).